Atlas Trials

Pharmacodynamic Effects of Sacubitril/Valsartan on Natriuretic Peptides, Angiotensin and Neprilysin

Clinical trial NCT03553303 · UNKNOWN

Trial details

NCT number
NCT03553303
Sponsor
Oslo University Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Heart Failure, Systolic
Start date
2018-10-16
Primary completion
2022-05-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.